Patents by Inventor Julien DUGAL-TESSIER

Julien DUGAL-TESSIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vaccine Compositions and Antibodies For Lyme Disease
    Publication number: 20230338495
    Abstract: The present invention relates to vaccine compositions comprising lipid antigens, antibodies targeting lipid antigens, pharmaceutical compositions comprising such and their use in diagnosing, monitoring, treating, and preventing infectious disease, such as Lyme disease. In one aspect, administered is a therapeutically effective amount of a vaccine composition comprising a lipid antigen, an antibody or fragment thereof binding a lipid antigen, and/or a pharmaceutical composition comprising an antibody or fragment thereof binding a lipid antigen. Other aspects are described.
    Type: Application
    Filed: August 19, 2021
    Publication date: October 26, 2023
    Inventors: Mahiuddin AHMED, Sonia SEQUEIRA, Julien DUGAL-TESSIER, Bram Pieter KARSTEN, Nareshkumar JAIN
  • DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES
    Publication number: 20220204557
    Abstract: Provided are peptide analogs, pharmaceutical compositions comprising such compounds, and methods of treating cancer with such compounds.
    Type: Application
    Filed: March 18, 2022
    Publication date: June 30, 2022
    Applicant: AGENSYS, INC.
    Inventors: Brian Alan MENDELSOHN, Julien DUGAL-TESSIER, Stuart Daniel BARNSCHER
  • Derivatives of dolaproine-dolaisoleucine peptides
    Patent number: 11312748
    Abstract: Provided are peptide analogs, pharmaceutical compositions comprising such compounds, and methods of treating cancer with such compounds.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: April 26, 2022
    Assignee: AGENSYS, INC.
    Inventors: Brian Alan Mendelsohn, Julien Dugal-Tessier, Stuart Daniel Barnscher
  • DERIVATIVES OF DOLAPROINE-DOLAISOLEUINE PEPTIDES
    Publication number: 20200325170
    Abstract: Provided are peptide analogs, pharmaceutical compositions comprising such compounds, and methods of treating cancer with such compounds.
    Type: Application
    Filed: November 14, 2019
    Publication date: October 15, 2020
    Applicant: AGENSYS, INC.
    Inventors: Brian Alan MENDELSOHN, Julien DUGAL-TESSIER, Stuart Daniel BARNSCHER